Clinical Trial Update: A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial evaluated the combination of mycophenolate mofetil and rilonacept in patients with alcoholic hepatitis, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Arcalyst (rilonacept)
• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-25